Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • vaccination
  • Page 2

Tag: vaccination

  • BiotechToday
  • World

Longer gap between vaccine doses: Effective or not?

BioTech Today July 8, 2021July 7, 2021

Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]

Read More
  • BiotechToday
  • World

Understanding the potential of the Coronavirus alpha variant

BioTech Today July 3, 2021July 3, 2021 3

Neha khan, Jamia Millia Islamia What is the alpha variant? The B.1.1.7 variant is known as the Alpha variant which was first found in India and had taken thousands of lives. This coronavirus variant is more infectious than other variants because it foils the innate immune system for a while till it replicates and finds […]

Read More
  • BiotechToday
  • World

Analysis of the interaction sites of SARS-CoV-2

bioxone June 30, 2021June 29, 2021 1

Avani Dave, Jai Hind College. It has been more than half a century that the Coronaviruses (CoVs) have been rampantly spreading across the globe. This has led to the current pandemic caused by SARS-CoV-2, which extends a momentum to be able to characterize the largely expressed protein, the Nucleocapsid (N) protein. This N protein is […]

Read More
  • BiotechToday
  • World

Vaccine for Covid positive HIV patients

BioTech Today June 21, 2021June 20, 2021 2

Agrima Bhatt, Rajasthan University SARS-CoV-2 vaccination data has proven to lower the morbidity and mortality associated with COVID-19. However, this data severely lacks research among people suffering from immunodeficiency disorders, such as AIDS. In events of such opportunistic infections, where the human body is unable to produce the required immune response, the person is said […]

Read More
  • Biotechnopedia
  • DNA-Tales

COVID-19 Vaccines Around The World

bioxone May 17, 2021May 17, 2021 2

Souhrid Sarkar, Amity University Kolkata What is COVID-19? Coronaviruses are a family of viruses that may cause mild to severe respiratory disorders including death. The term ‘Corona’ means crown-like spikes on the surface of the virus. Some of the examples of coronavirus are Severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS), and […]

Read More
  • BiotechToday
  • World

Vaccines for children: as the race against COVID surges!

bioxone April 13, 2021April 13, 2021 2

Thota Kanishka Rao, Amity University Kolkata With the COVID-19 vaccine doing its rounds thorough out the world, the chances of contracting other variants of the virus are rising rapidly. At present, the vaccine provides an 85-90% immunity from the initial virus but is not known to be immune against the mutated versions of the virus.  […]

Read More
  • BiotechToday
  • World

Are viral vaccines safe for children with an autoimmune disorder?

bioxone February 16, 2021February 16, 2021 2

Husna, Amity University Kolkata An autoimmune disease is a condition in which the immune system mistakenly attacks the healthy cells of the body. Children with autoimmune diseases often require treatment with immunosuppressive drugs. So, in these patients, the efficacy and safety of vaccination, particularly the live attenuated vaccines remain a concern.  As the live attenuated […]

Read More
  • BiotechToday
  • World

Decreased efficacy of AstraZeneca vaccines on S. African strains

bioxone February 11, 2021February 11, 2021 1

Rohit Bhattacharjee, Amity University, Kolkata. The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain. The University of Witwatersrand, Johannesburg, which conducted the in which they stated that the vaccine provided minimal protection against mild-moderate COVID-19 infection. The data, which has not yet undergone peer review appeared to confirm the theoretical […]

Read More
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Read More
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020 2

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Read More

Posts navigation

1 2 3

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy